Foresee Pharmaceuticals Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 10, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	13,328	11,995	13,062	10,797	14,047	10,474
Market Cap Growth	12.86%	-8.16%	20.98%	-23.14%	34.12%	79.10%
Enterprise Value	12,820	11,645	11,754	9,869	12,654	10,323
Last Close Price	84.60	77.50	96.18	90.37	118.16	88.59
Forward PE	-	-	-	-	-	18.90
PS Ratio	25.65	28.65	66.97	35.81	62.15	45.45
PB Ratio	12.54	7.50	10.50	11.86	10.64	5.73
P/TBV Ratio	14.02	8.10	11.69	14.03	12.06	6.47
EV/Sales Ratio	24.67	27.81	60.27	32.73	55.98	44.80
Debt / Equity Ratio	0.33	0.16	0.18	0.05	0.01	0.07
Net Debt / Equity Ratio	-0.48	-0.69	-0.75	-0.71	-0.95	-0.81
Net Debt / EBITDA Ratio	0.44	1.09	0.98	1.51	2.51	3.34
Net Debt / FCF Ratio	0.37	0.84	1.00	2.23	5.69	2.17
Asset Turnover	0.34	0.21	0.12	0.21	0.12	0.15
Inventory Turnover	0.98	1.15	0.54	0.25	1.73	1.54
Quick Ratio	2.73	3.63	2.65	5.54	17.12	13.45
Current Ratio	3.67	4.62	3.38	7.08	17.51	13.87
Return on Equity (ROE)	-138.70%	-76.04%	-96.17%	-42.38%	-36.15%	-37.48%
Return on Assets (ROA)	-50.05%	-33.57%	-39.79%	-19.92%	-18.00%	-19.49%
Return on Capital Employed (ROCE)	-99.10%	-61.10%	-72.50%	-40.00%	-34.40%	-24.50%
Earnings Yield	-9.20%	-9.01%	-7.93%	-4.38%	-4.05%	-4.88%
FCF Yield	-10.23%	-11.03%	-7.15%	-2.70%	-1.57%	-6.57%
Buyback Yield / Dilution	-10.78%	-7.89%	-7.82%	-0.57%	-15.74%	-5.71%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.